Mounjaro Alternatives in District of Columbia
Compare generic and therapeutic alternatives to Mounjaro (tirzepatide) available at District of Columbia pharmacies. Save up to 40% on your prescription — no insurance required.
Top Alternatives in District of Columbia
Ozempic (semaglutide)
therapeutic
GLP-1 agonist — comparable weight-loss and diabetes efficacy
Avg cash price: $940/mo
Wegovy (semaglutide)
therapeutic
Higher-dose semaglutide approved for weight loss
Avg cash price: $1350/mo
Compounded tirzepatide
therapeutic
Available from Script Unlock compounding pharmacies during shortage
Avg cash price: $300/mo
District of Columbia Prescription Assistance Programs
DC Medicaid Rx (DC Health Care Alliance)
Prescription drug coverage for DC Medicaid beneficiaries and uninsured DC residents with incomes up to 200% FPL through the DC Health Care Alliance program.
Eligibility: Low-income DC residents including adults up to 215% FPL for Medicaid, and uninsured adults through the Alliance program.
DCPAP (DC Pharmaceutical Assistance Program)
Assists eligible low-income DC seniors with Medicare Part D co-payments and coverage gaps.
Eligibility: DC residents aged 65+ enrolled in Medicare Part D with income at or below 300% FPL. Contact the DC Office on Aging at 202-724-5622.
Frequently Asked Questions
What is cheaper than Mounjaro?
Compounded tirzepatide (available during FDA shortage periods) can be significantly cheaper — often $200–$400/month from compounding pharmacies in the Script Unlock network.
Is semaglutide (Ozempic/Wegovy) a good Mounjaro alternative?
Both target weight loss and blood sugar. Tirzepatide (Mounjaro/Zepbound) showed greater average weight loss in trials, but semaglutide is well-established and may be covered differently by insurance.
How does Script Unlock help with Mounjaro costs?
Script Unlock connects you with pharmacies that carry compounded tirzepatide and may offer competitive pricing on brand Mounjaro or Zepbound.